Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
Position
Chief Business Officer
Company
Zenas BioPharma
WalthamBiotechnologyHealth CareTherapeuticsDescription
Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology directed therapies, today announced the appointment of Jennifer Fox as its Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., Ph. D as Head of Research and Development and Chief Medical Officer.
Quick answer
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer (December 4, 2023). Zenas BioPharma is based in Waltham, Massachusetts, United States.
- Who is the new Chief Business Officer at Zenas BioPharma?
- Zenas BioPharma named Jennifer Fox Chief Business Officer, announced December 4, 2023.
- What did Zenas BioPharma announce on December 4, 2023?
- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology directed therapies, today announced the appointment of Jennifer Fox as its Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., Ph. D as Head of Research and Development and Chief Medical Officer.
- What does Zenas BioPharma do?
- Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies for patients in need around the world.
- Where is Zenas BioPharma based?
- Zenas BioPharma is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- TScan Therapeutics, Inc. (December 4, 2023), Chimerix (December 4, 2023), Smart Immune (December 4, 2023) and Applied StemCell (December 4, 2023) also announced leadership changes within 45 days of Zenas BioPharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer (December 4, 2023)
- Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer (December 4, 2023)
- Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise (December 4, 2023)
- Applied StemCell, Inc. Strengthens Executive Leadership with Two Key Appointments (December 4, 2023)
- Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer (December 6, 2023)
- Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage (December 7, 2023)
Who to call at Zenas BioPharma, and when
A new leader at Zenas BioPharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Zenas BioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zenas BioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zenas BioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zenas BioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Zenas BioPharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.